Study Summary
This trial will study the effectiveness of a new, shorter treatment for major depression, comparing it to a standard treatment.
- Major Depression
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 4 Secondary · Reporting Duration: 7 months
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
Bilateral TBS
1 of 4
Maintenance Phase: Fixed
1 of 4
Unilateral TBS
1 of 4
Maintenance Phase: Flexible
1 of 4
Active Control
256 Total Participants · 4 Treatment Groups
Primary Treatment: Bilateral TBS · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the current participant count for this medical experiment?
"Affirmative. Clinicaltrials.gov documents that this medical trial, first published on December 12th 2019, is currently recruiting participants from one location. A total of 256 patients need to be enrolled in the research study." - Anonymous Online Contributor
Is this research initiative still welcoming participants?
"According to the information hosted by clinicaltrials.gov, this trial is actively recruiting and was initially posted on December 12th 2019 with a most recent edit occurring on June 7th 2022." - Anonymous Online Contributor
What purpose does this research endeavor seek to achieve?
"The primary metric of this 6-month trial is Remission - Treatment Phase (Hamilton Rating Scale for Depression-17 Score). Secondary outcomes include Response - Maintenance Phase and Response - Treatment Phase, both assessed by the Quick Inventory of Depression Symptomology-Self Report. Lastly, there's also a measure for Remission as defined by a score ≤ 6 on the same scale." - Anonymous Online Contributor